StockData
Silexion Therapeutics Corp logo

Silexion Therapeutics Corp (SLXN) stock

SLXNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SLXNW
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$1.44−0.21 (-12.73%)

Close on Nov 18, 2026Market cap $868.40KP/E –Yield –

Silexion Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Silexion Therapeutics's price to book ratio was 86.6× on Nov 11, 2026, against 72.6× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202686.6×−119.9
2025Dec 31, 2025206.5×–

More Silexion Therapeutics figures

See a number that looks wrong?